Fibralign
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
32930 Alvarado Niles Rd Ste 350, Union C...Phone Number
(415) 902-4721Website
www.fibralignbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Fibralign
Fibralign is an award-winning, Stanford-spinout company that specializes in developing innovative therapeutic biomedical devices aimed at addressing significant unmet medical needs. Their flagship product, the BioBridge Collagen Matrix, is designed for the treatment of secondary lymphedema, a chronic condition with no current cure. The company utilizes its proprietary Nanoweave technology to create scaffolding that mimics human tissue, facilitating the body's repair functions. Fibralign's products are commercially available in the US, Europe, South Korea, and the Middle East, and have been used in over 750 surgeries across 19 countries.Explore more
Fibralign Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Fibralign your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Fibralign is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Fibralign
Check if Fibralign has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Fibralign recently announced quarterly report
Product Launch: Get notified when Fibralign launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Fibralign has new funding data
Fibralign, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Fibralign had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Fibralign
Find 2 more new buyers
Compare Similar Companies to Fibralign
Compare insights from companies similar to Fibralign, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Fibralign is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Fibralign is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Fibralign.
Fibralign Tech Stack
A closer look at the technologies used by Fibralign
Fibralign News & Media
Fibralign annonce l’approbation du marquage CE pour le dispositif BioBridge®
UNION CITY, Californie--(BUSINESS WIRE)--Fibralign Corp., une société issue de Stanford et mettant au point des dispositifs biomédicaux thérapeutiques, a annoncé aujourd’hui avoir reçu le marquage CE pour son premier produit, la BioBridge® Collagen Matrix. Classé comme un dispositif de classe III dont l’indication d’utilisation consiste à soutenir la réparation des tissus lymphatiques, BioBridge peut être utilisé après ou en conjonction avec des interventions chirurgicales traitant le lymphœdèmFibralign Announces CE Mark Approval for BioBridge®
UNION CITY, Calif.--(BUSINESS WIRE)--Fibralign Corp., a Stanford spin-out and developer of therapeutic biomedical devices, today announced that it has received CE mark for its first product, the BioBridge® Collagen Matrix. BioBridge is classified as a Class III device with an indication for use to support lymphatic tissue repair and can be used after or in conjunction with surgical procedures addressing lymphedema. CE mark is a certification symbol in Europe that signals conformity to patient sFibralign Announces Strategic Partnership With Terumo
UNION CITY, Calif.--(BUSINESS WIRE)-- #BioBridge--Strategic Partnership with Fibralign and Terumo to market BioBridge in Japan for both the treatment and prevention of Lymphedema.Fibralign Raises Funding from Investor Syndicate of AngelMD
Fibralign, Inc., a Union City CA-based maker of therapeutic medical devices for regenerative medicine, raised funding from a syndicate of AngelMD, an investment and networking platform connecting innovative medical startups, physicians, investors, and industry partners. The amount of the deal was not disclosed. Led by Greg King, CEO, Fibralign leverages patented Nanoweave® 3D scaffolding technology […]
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Fibralign
Sign Up For FreeTo access detailed company insights
Fibralign is an award-winning, Stanford-spinout company that specializes in developing innovative therapeutic biomedical devices aimed at addressing significant unmet medical needs. Their flagship product, the BioBridge Collagen Matrix, is designed for the treatment of secondary lymphedema, a chronic condition with no current cure. The company util... Read More
